Best Blood Collection Suppliers in the U.S.: Medline vs. McKesson, Cardinal Health, and Henry Schein

Summary

• Medline Industries generally offers the strongest overall balance of blood collection product breadth, competitive contract pricing, inventory availability, and delivery support for many U.S. hospitals, laboratories, physician practices, and ambulatory centers.
• McKesson Medical-Surgical and Cardinal Health can be better choices for organizations that prioritize national distribution scale, integrated purchasing, or existing health-system contracts, while Henry Schein is often well suited to smaller physician and dental practices.
• The best supplier should be selected through a documented comparison of total landed cost, product quality, regulatory compliance, fill rate, delivery performance, substitutions, expiration dating, and emergency-order capability rather than unit price alone.

Choosing a blood collection supplier in the United States is more complicated than comparing the price of a box of evacuated tubes. A dependable purchasing program must balance clinical performance, regulatory compliance, product availability, shipping reliability, contract terms, and the cost of receiving, storing, and managing supplies.

Blood collection products are used in almost every area of healthcare. Hospitals, reference laboratories, physician offices, urgent care centers, dialysis facilities, Mobile Phlebotomy services, blood donation organizations, veterinary practices, and public-health programs all rely on products such as evacuated blood collection tubes, needles, holders, syringes, tourniquets, transfer devices, safety lancets, specimen bags, labels, and transport materials.

For most U.S. buyers, there is not one universally superior supplier. The best option depends on the organization’s size, Laboratory Information System, annual usage, geographic footprint, existing group purchasing organization, and tolerance for backorders. However, when product selection, pricing, and delivery are evaluated together, Medline Industries is frequently a strong all-around choice. McKesson Medical-Surgical and Cardinal Health are highly competitive alternatives, particularly for large health systems and organizations that value broad distribution infrastructure. Henry Schein can be a practical choice for smaller office-based customers.

Why Blood Collection Purchasing Requires More Than a Price Comparison

Blood collection is a preanalytical process, meaning that many errors occur before a specimen reaches the analyzer. The World Health Organization has repeatedly identified the preanalytical phase as a major source of laboratory error. Published studies commonly report that preanalytical problems account for approximately 46% to 68% of laboratory errors, although the exact percentage varies by facility, test mix, and reporting method.

Incorrect tube selection, insufficient fill volume, hemolysis, clotting, contamination, mislabeling, improper mixing, and delayed transport can create recollection work. The cost of a recollection includes more than another tube. It may involve additional staff time, a second patient visit, delayed diagnosis, wasted reagents, increased patient dissatisfaction, and possible treatment delays.

As a result, a product that costs a few cents less per unit may be more expensive overall if it produces higher rejection rates, inconsistent draw performance, or frequent substitutions. Purchasing departments should evaluate total cost of ownership rather than invoice price alone.

The main cost categories

1. Product acquisition cost, including the negotiated price per tube, needle, syringe, or collection set.
2. Freight, fuel surcharges, minimum-order charges, and other delivery fees.
3. Inventory carrying costs, including storage space, expiration management, cycle counting, and shrinkage.
4. Labor costs associated with ordering, receiving, stocking, documenting, and resolving shortages.
5. Clinical costs caused by recollections, rejected specimens, needlestick incidents, and Workflow interruptions.
6. Emergency purchasing costs when standard supplies are unavailable.

A useful procurement analysis should therefore compare the delivered cost per successful collection, not merely the quoted price per package.

Major Blood Collection Suppliers in the United States

The U.S. market contains both manufacturers and distributors. A manufacturer produces the collection system, while a distributor may sell products from several manufacturers and deliver them with other medical supplies. This distinction matters because many healthcare organizations purchase their tubes from one brand, needles from another, and general consumables through a national distributor.

Medline Industries

Medline is one of the largest privately held medical supply companies in the United States and offers a broad portfolio of laboratory, surgical, patient-care, and infection-prevention products. Its blood collection catalog commonly includes evacuated tubes, safety needles, holders, syringes, blood transfer devices, specimen containers, labels, transport bags, sharps containers, and related accessories.

Medline’s primary strength is breadth. A hospital or outpatient network can often consolidate a significant number of line items through one account. This can reduce the number of purchase orders, invoices, deliveries, and vendor-management tasks. Medline also operates distribution centers throughout the United States, which can support regional delivery and replenishment programs.

Pricing is usually strongest when the buyer has meaningful volume, participates in a group purchasing arrangement, or is willing to standardize products. Smaller practices may not receive the same contract rates as major health systems, but they can still benefit from catalog availability and consolidated ordering.

Medline is particularly attractive when a buyer wants one primary supplier for blood collection products and other routine medical supplies. Its main limitation is that the best product for a specialized laboratory may be a manufacturer-direct item with technical features that are not the lowest-cost option in a broad distributor catalog.

McKesson Medical-Surgical

McKesson is one of the largest healthcare distribution companies in the United States. Its medical-surgical business serves hospitals, physician practices, laboratories, long-term-care organizations, and other healthcare customers. The company’s scale can be valuable for customers that already use McKesson for pharmaceuticals, medical supplies, or practice-management services.

McKesson offers access to multiple blood collection brands and can support purchasing consolidation. Its national infrastructure is an important advantage for multisite organizations that need consistent ordering and delivery across several states. McKesson may also be competitive when a health system has a preexisting enterprise agreement or group purchasing relationship.

However, a very broad catalog can create complexity. Buyers should confirm the exact manufacturer, catalog number, tube additive, size, closure color, expiration date, and compatibility with their instruments. A generic description such as “serum tube” is not sufficient for a controlled laboratory supply program.

Cardinal Health

Cardinal Health is another major healthcare services and distribution company with significant reach across hospitals, laboratories, physician offices, and other care settings. Its advantages include distribution scale, supply-chain capabilities, private-label options, and the ability to combine blood collection products with a broad range of medical-surgical supplies.

Cardinal can be especially competitive for large integrated delivery networks that already have an enterprise relationship with the company. Contract pricing may improve when blood collection supplies are bundled with other categories. Customers should nevertheless examine product-level performance because a lower enterprise price does not automatically guarantee the best tube, needle, or specimen transport system for every department.

For organizations with high daily usage, Cardinal’s logistics capabilities may help reduce stockouts. The buyer should request service-level data for the specific distribution center and product family rather than relying only on national company statistics.

Henry Schein

Henry Schein is well known for serving dental and office-based healthcare markets, but it also supplies medical products used by physician practices, ambulatory facilities, and smaller laboratories. It can be a convenient option for customers that prefer a user-friendly ordering environment and do not require the procurement complexity of a large hospital contract.

Henry Schein may be a good fit for primary-care offices, specialty clinics, urgent care centers, and small practices that purchase modest quantities of tubes, needles, lancets, and specimen supplies. Its weakness for large laboratory systems may be less emphasis on highly customized enterprise logistics compared with the biggest medical-surgical distributors.

Manufacturer-direct options

Some buyers should compare distributors with direct purchasing from major blood collection manufacturers, including Becton, Dickinson and Company, Greiner Bio-One, and other established suppliers. Manufacturer-direct purchasing can provide stronger technical support, lot-specific documentation, standardized product training, and better control over a particular collection system.

BD is widely recognized for its Vacutainer blood collection portfolio and safety-engineered devices. Greiner Bio-One is known for its VACUETTE system. Sarstedt and other international manufacturers also serve the U.S. market. These companies may be especially relevant when tube performance, analyzer compatibility, automation, or laboratory standardization is more important than consolidating all medical supplies with one distributor.

The disadvantage of manufacturer-direct purchasing can be a higher administrative burden. The buyer may need separate accounts for tubes, needles, transport materials, and general consumables. Minimum order quantities, freight terms, lead times, and allocation policies should be reviewed carefully.

How Product Quality Should Be Evaluated

Product quality is not simply a matter of brand reputation. It must be evaluated against the intended use and the laboratory’s procedures. A tube that works well for routine chemistry may not be appropriate for coagulation, molecular testing, blood cultures, trace-element testing, or specialized therapeutic-drug monitoring.

Evacuated tube specifications

Each tube should be reviewed for additive, draw volume, material, dimensions, closure, expiration dating, and intended testing. Common categories include serum tubes, serum separator tubes, lithium-Heparin plasma tubes, sodium-citrate coagulation tubes, EDTA tubes, fluoride or glycolysis-inhibitor tubes, trace-element tubes, and blood-culture bottles.

Coagulation tubes deserve special attention because the blood-to-citrate ratio is critical. A standard sodium-citrate tube is generally designed around a 9-to-1 ratio of blood to anticoagulant. Underfilling can affect Test Results, particularly for coagulation assays. The supplier should provide clear specifications and lot documentation.

Tube performance should also be assessed for hemolysis, clot formation, gel movement, leakage, stopper integrity, vacuum consistency, and compatibility with the laboratory’s analyzers and automation lines. The Clinical and Laboratory Standards Institute publishes widely used guidance for venous blood collection, specimen handling, and related laboratory procedures. Buyers should align product selection with current internal procedures and applicable standards.

Needles and safety devices

Needle quality affects patient comfort, collection success, blood flow, and staff safety. A procurement review should consider Needle Gauge, length, bevel design, tubing length, activation method, visibility of safety features, and compatibility with holders and collection sets.

The Occupational Safety and Health Administration’s bloodborne pathogens standard requires employers to use engineering and work-practice controls and to evaluate safer medical devices where appropriate. The Needlestick Safety and Prevention Act also strengthened requirements related to safer needle technologies and employee involvement in device selection.

A low-cost device that is difficult to activate, prone to leakage, or poorly suited to the facility’s Workflow may create more risk than it saves. Organizations should involve phlebotomists and nurses in product trials before making a conversion.

Packaging and labeling

Packaging should protect tubes and devices from damage during transport and storage. Individual or small-unit packaging can be useful in high-control environments but may create more waste. Bulk packaging may reduce cost while increasing handling requirements.

Labels should support positive patient identification and comply with facility policy. The supplier should be able to provide consistent lot numbers, expiration dates, barcodes, and documentation for recalls or product complaints. If supplies are used with automated systems, barcode format and readability must be verified before conversion.

Pricing: What a Competitive Quote Should Include

Pricing in the U.S. medical-supply market varies substantially by volume, contract status, location, product brand, and supply conditions. A small office may pay a materially different price from a hospital purchasing hundreds of thousands of tubes each year. Online catalog prices are therefore useful for initial benchmarking but should not be treated as a final market comparison.

A formal request for quotation should contain estimated annual usage by exact catalog number. It should also specify whether the quoted price includes freight, handling, hazardous-material charges, fuel surcharges, minimum-order requirements, and expedited delivery.

Important commercial terms

1. Price per inner box, case, and pallet, with the unit of measure clearly defined.
2. Tiered pricing based on annual volume and whether purchases are consolidated.
3. Contract duration, renewal terms, price-increase notification, and inflation adjustments.
4. Freight thresholds and charges for orders below the free-shipping minimum.
5. Return policies for excess, damaged, expired, or incorrectly shipped products.
6. Substitution rules, including whether the supplier may ship an alternative brand without approval.
7. Payment terms, rebates, administrative fees, and group purchasing organization requirements.
8. Expiration-date guarantees and the process for replacing short-dated products.

Buyers should calculate the effective price after rebates and freight. For example, a lower case price may be offset by a shipping charge or a high minimum order that increases inventory waste. Conversely, a slightly higher unit price may be preferable if the supplier provides frequent scheduled deliveries and dependable emergency service.

Reliable Delivery and Inventory Performance

Delivery reliability is one of the most important differentiators among national suppliers. Healthcare organizations should request performance information rather than accepting general statements about distribution capacity. Useful measures include fill rate, on-time delivery, backorder frequency, order accuracy, average lead time, and emergency-order response.

Fill rate is the percentage of ordered units shipped complete. A 98% fill rate sounds strong, but at a facility ordering 500,000 collection tubes annually, a 2% shortfall represents approximately 10,000 units. If shortages occur in critical tube types, the operational impact may be substantial.

On-time delivery should be measured against the promised delivery date, not merely the date the order leaves the warehouse. A shipment that arrives two days late may still be recorded as shipped on time by a weak measurement system.

Questions to ask prospective suppliers

1. What is the historical fill rate for the exact blood collection products being quoted?
2. How many distribution centers normally stock the products?
3. What is the standard lead time for routine and emergency orders?
4. How are allocations handled during manufacturer shortages?
5. Will substitutions occur automatically, and how are clinical approvals documented?
6. Can the supplier provide lot, expiration, and recall information electronically?
7. What cutoff time applies to same-day shipment?
8. What escalation process is available when a critical item is backordered?

A supplier with multiple regional warehouses may offer faster delivery, but geographic proximity does not guarantee inventory. The buyer should confirm whether the quoted item is stocked locally or shipped from a centralized facility.

Comparing the Leading Options

Medline is often the strongest general-purpose choice for organizations seeking a balance of breadth, pricing, and delivery. It is especially appealing when the customer wants to consolidate blood collection products with other medical-surgical categories. Its value is greatest when contract volume and standardization can be used to negotiate pricing.

McKesson is a strong alternative for customers already integrated into McKesson’s distribution and purchasing systems. It may be preferable when enterprise logistics, national account management, and access to multiple brands are the primary goals.

Cardinal Health is similarly competitive for large health systems and high-volume customers. Its supply-chain scale and contracting structure can create favorable economics, but the buyer should evaluate product-level availability and clinical performance rather than choosing solely on corporate size.

Henry Schein can be the most convenient option for smaller practices that need modest quantities and straightforward ordering. Its total value may be better than a large distributor’s offer when administrative simplicity and customer service are more important than pallet-level pricing.

Manufacturer-direct purchasing from BD, Greiner Bio-One, Sarstedt, or another specialized supplier may provide the best clinical consistency for a laboratory with strict standardization requirements. It may not, however, provide the lowest total administrative cost.

A Practical Scorecard for Supplier Selection

A structured scorecard helps prevent a procurement decision from being driven by the lowest initial quote. The following weighting can be adapted to the organization’s priorities.

1. Product quality and clinical suitability: 30%.
2. Delivered price and contract economics: 25%.
3. Fill rate and delivery reliability: 20%.
4. Regulatory documentation, recalls, and customer support: 10%.
5. Inventory visibility, electronic ordering, and reporting: 5%.
6. Training, implementation assistance, and conversion support: 5%.
7. Sustainability, packaging efficiency, and waste considerations: 5%.

For a remote clinic or Mobile Phlebotomy company, delivery reliability may deserve a 30% or 35% weighting. For a large automated laboratory, analyzer compatibility and product consistency may deserve more than 40%. The scorecard should reflect operational risk rather than use identical weights for every buyer.

Recommended evaluation process

1. Document current annual usage by exact item, department, location, and season.
2. Identify products that are clinically critical or difficult to substitute.
3. Invite at least three qualified suppliers to submit comparable quotes.
4. Request samples and conduct a controlled evaluation with phlebotomists, nurses, and laboratory staff.
5. Review technical documentation, regulatory status, safety features, and compatibility.
6. Calculate total delivered cost, including freight, labor, waste, and inventory requirements.
7. Check references from organizations with a similar size and care setting.
8. Negotiate service levels, substitutions, expiration guarantees, and shortage communication.
9. Run a pilot at one or more locations before implementing a systemwide conversion.
10. Monitor performance after implementation and use quarterly business reviews to correct problems.

Regulatory and Compliance Considerations

U.S. buyers should verify that products are appropriately authorized, registered, listed, or otherwise compliant for their intended use under applicable Food and Drug Administration requirements. The exact regulatory pathway varies by product type. Safety-engineered needles, blood collection tubes, specimen containers, and transport products may have different regulatory classifications and documentation requirements.

Suppliers should be able to provide manufacturer information, lot traceability, certificates or declarations when applicable, safety data where required, and recall notifications. The purchasing department should maintain records showing which products were used during a specific period, particularly for products connected to patient specimens.

Facilities should also review infection-control requirements, sharps disposal practices, employee training, and bloodborne-pathogen procedures. A supplier’s product should fit the organization’s policies rather than requiring staff to create informal workarounds.

Managing Shortages and Supply-Chain Risk

The medical-supply disruptions of the early 2020s demonstrated the danger of relying on a single product, factory, or distribution channel. Blood collection supplies have experienced periodic shortages associated with manufacturing interruptions, transportation problems, raw-material constraints, unusual testing demand, and changes in healthcare utilization.

A resilience plan should identify primary and secondary sources for critical products. Dual sourcing does not mean using two incompatible tube systems simultaneously. It may involve validating an alternate manufacturer in advance and maintaining an approved conversion plan.

Organizations should maintain safety stock based on actual consumption and supplier lead time. A facility using 10,000 tubes per month with a normal lead time of one week may need less reserve inventory than a rural facility with a four-week replenishment cycle. The correct level depends on demand variability and the clinical consequences of a stockout.

Inventory should be rotated using first-expire, first-out practices. Excess stock can become unusable when a product expires or a laboratory changes its testing platform. Buyers should avoid accepting unusually large quantities merely to obtain a temporary discount unless storage capacity and consumption justify the purchase.

Final Recommendation

For many U.S. healthcare organizations, Medline offers the best overall combination of blood collection product breadth, competitive pricing, and dependable distribution. It is a particularly strong candidate for hospitals, ambulatory networks, physician groups, and laboratories that want to consolidate purchasing and negotiate based on broader medical-supply volume.

McKesson Medical-Surgical and Cardinal Health should be evaluated alongside Medline whenever an organization already has a relationship with either company or operates across multiple states. Their national scale may produce better pricing, stronger integration, or improved delivery performance under an existing enterprise agreement.

Henry Schein deserves consideration for smaller office-based customers that value convenient ordering and responsive account support. For specialized laboratories, manufacturer-direct purchasing from BD, Greiner Bio-One, Sarstedt, or another qualified manufacturer may provide better clinical standardization even if it does not produce the lowest apparent unit price.

The most defensible purchasing decision is therefore not “Which company is cheapest?” It is “Which supplier can provide the required product, at the required quality, on the required schedule, at the lowest total cost per successful collection?” A documented bid process, clinical product trial, service-level agreement, and ongoing performance review will usually produce a better result than selecting a supplier based on catalog price alone.

Disclaimer: The content provided on this blog is for informational purposes only, reflecting the personal opinions and insights of the author(s) on the topics. The information provided should not be used for diagnosing or treating a health problem or disease, and those seeking personal medical advice should consult with a licensed physician. Always seek the advice of your doctor or other qualified health provider regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website. If you think you may have a medical emergency, call 911 or go to the nearest emergency room immediately. No physician-patient relationship is created by this web site or its use. No contributors to this web site make any representations, express or implied, with respect to the information provided herein or to its use. While we strive to share accurate and up-to-date information, we cannot guarantee the completeness, reliability, or accuracy of the content. The blog may also include links to external websites and resources for the convenience of our readers. Please note that linking to other sites does not imply endorsement of their content, practices, or services by us. Readers should use their discretion and judgment while exploring any external links and resources mentioned on this blog.

Related Videos